Cooling Pain Relief

Description

Walgreens Cooling Pain Relief + Skin Moisturizing Cream is a topical analgesic formulation containing 4.5% menthol. This cream is designed to provide temporary relief from pain while simultaneously moisturizing the skin. It is enriched with aloe and vitamin E, which contribute to its soothing properties. The product is free from parabens and fragrance, making it suitable for sensitive skin. The net weight of the cream is 3 ounces (85 grams).

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. It provides soothing relief that moisturizes and comforts the affected areas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, the product should not be used without consulting a healthcare professional. It is essential to seek medical advice before administering this treatment to ensure safety and appropriateness for this age group.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects. Contact with the eyes must be avoided to prevent serious ocular complications. Additionally, tight bandaging is contraindicated as it may lead to compromised circulation and increased risk of tissue damage.

Warnings and Precautions

For external use only; this product is contraindicated for application on wounds or damaged skin. Healthcare professionals should advise patients to avoid contact with the eyes, as this may lead to irritation or injury. Additionally, it is important to instruct patients not to bandage the area tightly, as this could exacerbate potential adverse effects.

Patients should be closely monitored for any worsening of their condition. If symptoms persist beyond 7 days or if they resolve and then recur within a few days, patients are advised to discontinue use and consult their healthcare provider for further evaluation.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

To ensure safety, this product must be kept out of reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients using this product may experience various adverse reactions. It is important to note that this product is for external use only and should not be applied to wounds or damaged skin.

While using the product, patients should avoid contact with the eyes and should not bandage the area tightly. If the condition worsens, or if symptoms persist for more than 7 days or resolve and then recur within a few days, patients are advised to discontinue use and consult a healthcare professional.

In the context of pregnancy or breastfeeding, it is recommended that patients consult a health professional before using this product. Additionally, to ensure safety, the product should be kept out of reach of children.

In the event of overdosage, if the product is swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cooling Pain Relief (menthol 4.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication; consultation with a healthcare professional is advised. For children aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically studied in relation to dosage adjustments, special monitoring, or safety considerations. Consequently, there is no available information regarding the use of this medication in individuals with reduced kidney function. Healthcare professionals should exercise caution when prescribing this medication to patients with renal impairment, as the lack of data necessitates careful consideration of potential risks and benefits.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the potential toxicological profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to instruct patients not to apply the medication on wounds or damaged skin, as this may lead to adverse effects or hinder healing.

Patients should be informed to discontinue use if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms improve and then recur within a few days, patients should also stop using the medication and consult their healthcare provider.

Healthcare providers must emphasize the importance of avoiding contact with the eyes, as this could result in irritation or injury. Furthermore, patients should be cautioned against applying a tight bandage over the treated area, as this may affect the medication's efficacy and increase the risk of side effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 15° to 30° C (59° to 86° F) to maintain its efficacy and stability. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cooling Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)